Tfh dysfunction in HIV and Aging
HIV 和衰老中的 Tfh 功能障碍
基本信息
- 批准号:10256680
- 负责人:
- 金额:$ 76.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-30 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AIDS/HIV problemAddressAffectAgeAgingAntibodiesAntibody AffinityAntibody ResponseAntigensAutologousB-LymphocytesBindingBiological AssayCD4 Positive T LymphocytesCell CommunicationCell physiologyCellsCharacteristicsClassificationClonal ExpansionCoculture TechniquesCoupledData SetDefectDevelopmentDiabetic KetoacidosisDiseaseDoseEffectivenessElderlyEvaluationFailureFeasibility StudiesFloridaFlow CytometryFunctional disorderGeneral PopulationGenerationsHIVHIV InfectionsHIV SeronegativityHa antigenHelper-Inducer T-LymphocyteHomeImmuneImmune responseImmune systemImmunityImmunocompetenceImpairmentIn VitroIncidenceIndividualInflammagingInflammationInflammatoryInfluenzaInfluenza vaccinationInterleukin-2InterventionKineticsLeadLongevityLymphoid TissueMemory B-LymphocyteMonoclonal AntibodiesMyocardial InfarctionParticipantPeripheralPersonsPhenotypePhosphorylationPlant RootsPlasma CellsPopulationPropertyReportingResolutionRiskRoleSeasonsSerologySignal TransductionStat5 proteinStrokeStructure of germinal center of lymph nodeT-Lymphocyte SubsetsTNF geneTNFSF5 geneTechnologyTestingUnited StatesUp-RegulationVaccinationVaccinesViralVirusantiretroviral therapybasebioinformatics resourceco-infectioncomorbiditydata integrationfluhuman old age (65+)immune activationimprovedin vitro testingin vivoinflammatory markerinfluenza infectioninfluenza virus vaccineinsightinterestmonocytenovelperipheral bloodprogrammed cell death protein 1recruitresponders and non-respondersresponseseasonal influenzasenescencesingle-cell RNA sequencingsuccessvaccine responsevaccine-induced antibodiesvirology
项目摘要
With effective ART, HIV infected persons can achieve a near normal life span but have increasing incidence
of comorbidities and co-infections that occur earlier, are more frequent than the general population.
Underlying inflammation is considered to be a major factor for comorbidities, but less well appreciated is the
associated immune deficiency that persist even after durable virologic control, putting people living with HIV
(PWH) at greater risk for influenza, for which flu vaccinations are recommended. Besides decreasing risk for
influenza infection, flu vaccines can serve as probes for testing host immune competence an approach used
in this proposal and in a previous project (AI108472) for assessing immunity in PWH and we could classify
participants as vaccine responders (VR) and vaccine non-responders (VNR). We observed that aging and
HIV had a negative effect on vaccine response. In studying mechanisms of immune defects in VNR, we
identified quantitative and qualitative defects in peripheral T follicular helper cells (pTfh), which are a subset
of CD4 T cells that are essential for vaccine-induced antibody (Ab) responses. The pTfh displayed a
skewed polarization away from a favorable IL-21 secreting phenotype towards a detrimental IL-2 secreting
Th1 phenotype, coupled with abundance of inflammatory markers, resulting in failure of pTfh to provide B
cells with the helper signals required for Ab secretion. Our central hypothesis is that skewed polarization of
pTfh away from a favorable IL-21 secreting phenotype towards one of IL-2 and inflammation is detrimental,
worsens with age or HIV but is amenable to change by ex-vivo and in-vivo manipulation. We will recruit HIV
negative and virally suppressed HIV+ populations to address key questions on Ab response following
seasonal influenza vaccination. The project has 3 aims: Aim 1 will investigate cell-intrinsic properties of pTfh
cells that influence their function in the context of age, HIV infection and the generation of memory B cells.
Aim 2 will investigate VNR to define mechanism of pTfh dysfunction via study of cellular and molecular
interactions affecting pTfh function and will test in-vitro interventions to reverse the pTfh dysfunction. Aim 3
will test whether administering high dose flu vaccine improves immune response in VNR from all groups
and will investigate the immune mechanisms affected. In this project we will evaluate immune cell
populations of interest using a combination of technologies including multi-parameter flow cytometry, single
cell RNA sequencing, repertoire sequencing, monoclonal Ab generation and cell co- cultures to gain high
resolution datasets. Our approach will obtain a snapshot of immune perturbation of pTfh cells in aging and
HIV infection. In vitro studies with purified cell subsets will allow for mechanistic evaluation of the immune
system. These studies are feasible, given our expertise in the technologies described, access to desired
population and resources for bioinformatics and data integration. We expect to provide novel insights into
immune perturbations that will help in strategizing vaccine approaches in aging populations.
通过有效的抗逆转录病毒治疗,艾滋病毒感染者可以接近正常寿命,但发病率正在上升。
与普通人群相比,更早发生的合并症和混合感染更为常见。
潜在的炎症被认为是合并症的一个主要因素,但人们对
相关的免疫缺陷,即使在持久的病毒学控制后仍然存在,使艾滋病毒携带者
(PWH)患流感的风险较大,建议接种流感疫苗。除了降低风险之外
流感病毒感染后,流感疫苗可作为检测宿主免疫能力的一种方法
在这项提案和之前的一个项目(AI108472)中,我们可以将威斯康星医院的免疫力分类
参与者为疫苗应答者(VR)和疫苗无应答者(VNR)。我们观察到衰老和
HIV对疫苗的应答率有负面影响。在研究VNR的免疫缺陷机制时,我们
外周T滤泡辅助细胞(PTfh)的数量和质量缺陷已确定,这是一个亚群
对疫苗诱导的抗体(Ab)反应至关重要的CD4T细胞。PTfh显示了一个
从有利的IL-21分泌表型向有害的IL-2分泌表型倾斜的极化
Th1表型,再加上大量的炎症标志物,导致pTfh无法提供B
具有分泌抗体所需辅助信号的细胞。我们的中心假设是扭曲的极化
PTfh远离有利的IL-21分泌表型而转向其中一种IL-2且炎症是有害的,
随着年龄或艾滋病毒的增加而恶化,但可通过体外和体内操作而改变。我们将招募艾滋病毒感染者
阴性和病毒抑制的HIV+人群解决以下抗体应答的关键问题
季节性流感疫苗接种。该项目有三个目标:目标1将研究pTfh的细胞固有属性
在年龄、艾滋病毒感染和记忆B细胞生成的背景下影响其功能的细胞。
Aim 2将通过对细胞和分子的研究来研究VNR,以确定pTfh功能障碍的机制
影响pTfh功能的相互作用,并将测试体外干预以逆转pTfh功能障碍。目标3
将测试注射大剂量流感疫苗是否能改善所有组的VNR的免疫反应
并将调查受影响的免疫机制。在这个项目中,我们将评估免疫细胞
使用包括多参数流式细胞术在内的多种技术组合的感兴趣人群,
细胞RNA测序、曲线谱测序、单抗产生和细胞共培养获得高
分辨率数据集。我们的方法将获得pTfh细胞在衰老和
艾滋病毒感染。用纯化的细胞亚群进行的体外研究将允许对免疫的机械评估
系统。考虑到我们在所述技术方面的专业知识,这些研究是可行的,可以获得所需的
生物信息学和数据整合的人口和资源。我们希望对以下方面提供新的见解
免疫紊乱,将有助于在老龄化人口中制定疫苗方法的战略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SURESH PALLIKKUTH其他文献
SURESH PALLIKKUTH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SURESH PALLIKKUTH', 18)}}的其他基金
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 76.01万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 76.01万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 76.01万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 76.01万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 76.01万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 76.01万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 76.01万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 76.01万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 76.01万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 76.01万 - 项目类别:
Research Grant














{{item.name}}会员




